Drug Recall
Ongoing
Historical recordClass II
Vitamin B-Complex, a) 10 mL-vial, b) 30 mL-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Propionate 100mg/ml, 10mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Enanthate (GSO) 200mg/ml, a) 5 mL-vial, b) 10 mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Enanthate (GSO) 100mg/ml, 2 mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Cypionate/Propionate 180/20mg/ml, a) 5 mL-vial, b) 10 mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Cypionate/Enanthate/Propionate 80/80/40mg, a) 5 mL-vial, b) 10 ml-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Cypionate/Enanthate 100/100mg/ml, a) 2 mL-vial, b) 4 mL-vial c) 10 mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Cypionate/Anastrozole 200mg/1mg/mL, a) 4 mL-vial, b)10mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Cypionate/Anastrozole 200mg/0.5mg/mL, 10mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Cypionate (GSO) 200mg/ml a) 2 mL-vial, b) 4 mL-vial, c) 5 mL-vial, d) 10 mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Testosterone Cypionate (GSO) 100mg/ml a)1mL-vial , b) 2mL-vial, Room temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Teriparatide 226mcg/ml Injectable, 4 Pre-filled Syringes, 0.25 mL-Syringe, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Sermorelin/Glycine 2000mcg/5mg/mL, 7.5mL-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Sermorelin/Glycine 2000mcg/5mg/mL, 4mL-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Sermorelin 2000mcg/mL, 7.5mL-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Semaglutide/Cyanocobalamin 5mg/0.2mg/ml, 2ml-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Semaglutide/Cyanocobalamin 2mg/0.4mg/ml, 1mL-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
PT-141 10mg/mL a) 1mL-vial, b) 2 mL-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Procaine HCL 2% (20mg/mL), 30 ml-vial, Refrigerate, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
Drug Recall
Ongoing
Historical recordClass II
Pentosan Polysulfate Sodium 250mg/mL, 5mL-vial, Room Temperature, Tailor Made Compounding
by TMC Acquisition LLC dba Tailor Made Compounding
- Reason
- Lack of Assurance of Sterility
- Recall initiated
- March 7, 2022
- Reported by FDA
- July 20, 2022
- Distribution
- Nationwide USA and Puerto Rico
View recall →
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer.